• C3.ai recently announced the general availability of C3 Code, an agentic Enterprise AI development platform that generates full-stack, production-grade applications from natural language prompts and was scored 9.2 out of 10 in an external evaluation that compared it with offerings from OpenAI, Anthropic, and Palantir.
• By combining autonomous coding agents with its existing Agentic AI Platform and pre-built industry applications, C3.ai is positioning C3 Code as a way for enterprises to turn complex AI workloads into governed, deployable solutions in hours rather than the person-days or -weeks often required previously.
• We’ll now examine how C3 Code’s full-stack, agent-driven application generation could influence C3.ai’s investment narrative and longer-term adoption prospects.

AI is about to change healthcare. These 36 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

C3.ai Investment Narrative Recap

To own C3.ai, you have to believe that its agentic AI platform can turn today’s pilot projects into large, repeatable enterprise deployments despite steep revenue declines and continuing losses. C3 Code’s launch speaks directly to that thesis by targeting faster, production-grade rollouts, but it does not erase the immediate risk around shrinking revenue and market skepticism after a 46.1% year over year sales drop and ongoing net losses.

Among recent developments, the McKinsey alliance looks especially relevant alongside C3 Code. If C3.ai can pair McKinsey’s consulting reach with a platform that claims full-stack, prompt-driven app generation, it could help address the current bottleneck of turning proofs of concept into live systems, which remains central to both the bull case on adoption and the bear case on execution risk.

Yet, in sharp contrast, investors should also be aware that...

C3.ai's narrative projects $613.6 million revenue and $80.3 million earnings by 2028. This requires 16.4% yearly revenue growth and an earnings increase of about $369 million from -$288.7 million today.

Uncover how C3.ai's forecasts yield a $14.67 fair value, a 71% upside to its current price.

Exploring Other Perspectives

While consensus anchors on gradual improvement, the most bearish analysts saw revenue shrinking about 15% a year and still unprofitable by 2029, so you should weigh those harsher expectations against what C3 Code might change.

Explore 10 other fair value estimates on C3.ai - why the stock might be worth 30% less than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your C3.ai research is our analysis highlighting 1 important warning sign that could impact your investment decision.
• Our free C3.ai research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate C3.ai's overall financial health at a glance.

Contemplating Other Strategies?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Find 62 companies with promising cash flow potential yet trading below their fair value.
• Invest in the nuclear renaissance through our list of 93 elite nuclear energy infrastructure plays powering the global AI revolution.
• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.